PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
23.11%
Net income growth under 50% of MRVL's 66.85%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
1.43%
D&A growth well above MRVL's 0.61%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
247.68%
Well above MRVL's 60.00% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
5.88%
SBC growth well above MRVL's 5.13%. Michael Burry would flag major dilution risk vs. competitor’s approach.
37.81%
Less working capital growth vs. MRVL's 86.51%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
58.62%
AR growth well above MRVL's 40.76%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
62.52%
Inventory growth well above MRVL's 29.63%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-111.56%
Both negative yoy AP, with MRVL at -19.10%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
24.60%
Lower 'other working capital' growth vs. MRVL's 91.99%. David Dodd would see fewer unexpected short-term demands on cash.
-17.20%
Both negative yoy, with MRVL at -8.87%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
68.26%
Operating cash flow growth at 50-75% of MRVL's 104.86%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
55.10%
CapEx growth well above MRVL's 0.61%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-22.83%
Both yoy lines negative, with MRVL at -33.80%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-70.35%
We reduce yoy sales while MRVL is 112.90%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-100.13%
We reduce yoy other investing while MRVL is 2919.61%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-126.32%
We reduce yoy invests while MRVL stands at 551.76%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-3.04%
We cut debt repayment yoy while MRVL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Repurchase growth above 1.5x MRVL's 18.88%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.